Replicate Bioscience is applying advanced srRNA technology towards solving a life-threatening problem—drug resistance in cancers—using their proprietary synthetic immune lethality approach. They are also developing srRNA injections for sustained therapeutic protein expression, to treat inflammatory disorders and other conditions.

Biotechnology

Replicate Bioscience

Nathaniel Wang

Rachael Lester

Zelanna Goldberg, M.D., M.A.S.

Shigeki Miyake-Stoner

Parinaz (Paris) Aliahmad

Michael Ehlers

Darina Spasova

Christian J. Maine, Ph.D.

Zelanna Goldberg

Zachary Hartman

Herbert Kim Lyerly

Andrew Geall

Parinaz Aliahmad

The Research and Development Team at Replicate Bioscience is dedicated to advancing the company's mission of combating drug-resistant cancers and treating inflammatory disorders through cutting-edge srRNA technology. The team focuses on developing and optimizing proprietary synthetic immune lethality approaches and srRNA injections for sustained therapeutic protein expression, conducting rigorous scientific research, and translating innovative discoveries into clinical applications.

Research and Development Team

Leadership Team

Medical and Scientific Team

Research and Development Team

About

Team members

Other teams at Replicate Bioscience

Leadership Team

Medical and Scientific Team